US834985A
(en)
*
|
1905-09-28 |
1906-11-06 |
Simon Lake |
Sighting instrument.
|
US2652098A
(en)
|
1951-08-25 |
1953-09-15 |
American Seating Co |
Folding chair
|
US2738303A
(en)
*
|
1952-07-18 |
1956-03-13 |
Smith Kline French Lab |
Sympathomimetic preparation
|
GB1082206A
(en)
|
1963-07-02 |
1967-09-06 |
Applic Chimiques D Etudes & De |
Improved antibiotic medicine
|
US4132753A
(en)
|
1965-02-12 |
1979-01-02 |
American Cyanamid Company |
Process for preparing oral sustained release granules
|
US3634584A
(en)
*
|
1969-02-13 |
1972-01-11 |
American Home Prod |
Sustained action dosage form
|
US3870790A
(en)
*
|
1970-01-22 |
1975-03-11 |
Forest Laboratories |
Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
*
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US3916889A
(en)
|
1973-09-28 |
1975-11-04 |
Sandoz Ag |
Patient ventilator apparatus
|
GB1478759A
(en)
|
1974-11-18 |
1977-07-06 |
Alza Corp |
Process for forming outlet passageways in pills using a laser
|
DE2546096C2
(de)
*
|
1975-10-15 |
1983-08-25 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von 4-Alkyl- thiosemicarbaziden
|
US4063064A
(en)
|
1976-02-23 |
1977-12-13 |
Coherent Radiation |
Apparatus for tracking moving workpiece by a laser beam
|
JPS5535031A
(en)
*
|
1978-09-04 |
1980-03-11 |
Shin Etsu Chem Co Ltd |
Enteric coating composition
|
DE2950977A1
(de)
*
|
1978-12-22 |
1980-07-10 |
Donald E Panoz |
Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
|
CA1146866A
(en)
|
1979-07-05 |
1983-05-24 |
Yamanouchi Pharmaceutical Co. Ltd. |
Process for the production of sustained release pharmaceutical composition of solid medical material
|
DE3024416C2
(de)
*
|
1980-06-28 |
1982-04-15 |
Gödecke AG, 1000 Berlin |
Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
|
US4467378A
(en)
*
|
1980-11-19 |
1984-08-21 |
Staar S. A. |
Two step cassette return mechanism for cassette tape decks
|
US4539199A
(en)
|
1981-01-14 |
1985-09-03 |
Egyt Gyogyszervegyeszeti Gyar |
Sustained release pharmaceutical compositions
|
US4464378A
(en)
|
1981-04-28 |
1984-08-07 |
University Of Kentucky Research Foundation |
Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
|
US4377568A
(en)
*
|
1981-08-12 |
1983-03-22 |
Merck Sharp & Dohme (I.A.) Corp. |
Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same
|
DE3208791A1
(de)
*
|
1982-03-11 |
1983-09-22 |
Röhm GmbH, 6100 Darmstadt |
Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels
|
US4389393A
(en)
*
|
1982-03-26 |
1983-06-21 |
Forest Laboratories, Inc. |
Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
|
US4421736A
(en)
*
|
1982-05-20 |
1983-12-20 |
Merrel Dow Pharmaceuticals Inc. |
Sustained release diethylpropion compositions
|
US4443428A
(en)
|
1982-06-21 |
1984-04-17 |
Euroceltique, S.A. |
Extended action controlled release compositions
|
US4557925A
(en)
|
1982-07-08 |
1985-12-10 |
Ab Ferrosan |
Membrane-coated sustained-release tablets and method
|
AU1873783A
(en)
|
1982-10-08 |
1984-04-12 |
Verex Laboratories Inc. |
Constant release formulation
|
US4612008A
(en)
|
1983-05-11 |
1986-09-16 |
Alza Corporation |
Osmotic device with dual thermodynamic activity
|
US4548990A
(en)
*
|
1983-08-15 |
1985-10-22 |
Ciba-Geigy Corporation |
Crosslinked, porous polymers for controlled drug delivery
|
EP0147780A3
(de)
|
1984-01-03 |
1987-03-11 |
Merck & Co. Inc. |
Vorrichtung zur Freisetzung von Arzneistoffen
|
US4599342A
(en)
*
|
1984-01-16 |
1986-07-08 |
The Procter & Gamble Company |
Pharmaceutical products providing enhanced analgesia
|
DE3405378A1
(de)
|
1984-02-15 |
1985-08-22 |
Röhm GmbH, 6100 Darmstadt |
Arzneimittelueberzug
|
EP0172624B1
(de)
*
|
1984-06-27 |
1988-10-26 |
Nitto Electric Industrial Co., Ltd. |
Pulverüberzugsmischung auf Basis eines Epoxyharzes und eines Füllstoffs
|
US4629621A
(en)
*
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
US4894234A
(en)
*
|
1984-10-05 |
1990-01-16 |
Sharma Shri C |
Novel drug delivery system for antiarrhythmics
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
DE3686275T2
(de)
|
1985-01-11 |
1993-03-18 |
Teijin Ltd |
Praeparate mit verzoegerter freisetzung.
|
GB2170104A
(en)
|
1985-01-30 |
1986-07-30 |
Warner Lambert Co |
Coated pharmaceutical dosage forms
|
US4600645A
(en)
*
|
1985-01-31 |
1986-07-15 |
Warner-Lambert Company |
Process for treating dosage forms
|
US4772475A
(en)
|
1985-03-08 |
1988-09-20 |
Yamanouchi Pharmaceutical Co., Ltd. |
Controlled-release multiple units pharmaceutical formulation
|
NL8500724A
(nl)
*
|
1985-03-13 |
1986-10-01 |
Univ Groningen |
Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
|
US4728512A
(en)
|
1985-05-06 |
1988-03-01 |
American Home Products Corporation |
Formulations providing three distinct releases
|
DE3687541T2
(de)
*
|
1985-05-13 |
1993-05-13 |
Miles Inc |
Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.
|
GB8519310D0
(en)
|
1985-07-31 |
1985-09-04 |
Zyma Sa |
Granular active substances
|
DE3678644D1
(de)
|
1985-08-16 |
1991-05-16 |
Procter & Gamble |
Wirkstoffpartikel mit sowohl kontinuierlicher als auch schneller freisetzung.
|
GB8521350D0
(en)
*
|
1985-08-28 |
1985-10-02 |
Euro Celtique Sa |
Analgesic composition
|
US4892742A
(en)
|
1985-11-18 |
1990-01-09 |
Hoffmann-La Roche Inc. |
Controlled release compositions with zero order release
|
GB2186485B
(en)
|
1986-02-13 |
1988-09-07 |
Ethical Pharma Ltd |
Slow release formulation
|
US4904476A
(en)
|
1986-03-04 |
1990-02-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
US4794001A
(en)
|
1986-03-04 |
1988-12-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
US4863456A
(en)
|
1986-04-30 |
1989-09-05 |
Alza Corporation |
Dosage form with improved delivery capability
|
GB8613689D0
(en)
*
|
1986-06-05 |
1986-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
GB8613688D0
(en)
*
|
1986-06-05 |
1986-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
ES2058111T3
(es)
*
|
1986-06-10 |
1994-11-01 |
Euro Celtique Sa |
Composicion de liberacion controlada de dihidrocodeina.
|
US4861598A
(en)
*
|
1986-07-18 |
1989-08-29 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
US4970075A
(en)
|
1986-07-18 |
1990-11-13 |
Euroceltique, S.A. |
Controlled release bases for pharmaceuticals
|
IT1200178B
(it)
|
1986-07-23 |
1989-01-05 |
Alfa Farmaceutici Spa |
Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
|
US4760094A
(en)
|
1986-10-21 |
1988-07-26 |
American Home Products Corporation (Del.) |
Spray dried acetaminophen
|
US6024983A
(en)
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
GB8626098D0
(en)
|
1986-10-31 |
1986-12-03 |
Euro Celtique Sa |
Controlled release hydromorphone composition
|
IT1201136B
(it)
|
1987-01-13 |
1989-01-27 |
Resa Farma |
Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive
|
US5026560A
(en)
*
|
1987-01-29 |
1991-06-25 |
Takeda Chemical Industries, Ltd. |
Spherical granules having core and their production
|
US4873092A
(en)
|
1987-05-21 |
1989-10-10 |
Murata Kikai Kabushiki Kaisha |
Slow-releasing preparation
|
US5023088A
(en)
|
1987-06-25 |
1991-06-11 |
Alza Corporation |
Multi-unit delivery system
|
US5219575A
(en)
*
|
1987-06-26 |
1993-06-15 |
Duphar International Research B.V. |
Compositions with controlled zero-order delivery rate and method of preparing these compositions
|
DE3721721C1
(de)
*
|
1987-07-01 |
1988-06-09 |
Hoechst Ag |
Verfahren zur Umhuellung von Granulaten
|
US5068110A
(en)
*
|
1987-09-29 |
1991-11-26 |
Warner-Lambert Company |
Stabilization of enteric coated dosage form
|
SE8703881D0
(sv)
|
1987-10-08 |
1987-10-08 |
Haessle Ab |
New pharmaceutical preparation
|
US4948586A
(en)
|
1987-11-02 |
1990-08-14 |
Lim Technology Laboratories, Inc. |
Microencapsulated insecticidal pathogens
|
US4844896A
(en)
|
1987-11-02 |
1989-07-04 |
Lim Technology Laboratories, Inc. |
Microencapsulated insecticidal pathogens
|
US4971805A
(en)
|
1987-12-23 |
1990-11-20 |
Teysan Pharmaceuticals Co., Ltd. |
Slow-releasing granules and long acting mixed granules comprising the same
|
US5460817A
(en)
|
1988-01-19 |
1995-10-24 |
Allied Colloids Ltd. |
Particulate composition comprising a core of matrix polymer with active ingredient distributed therein
|
EP0327295A3
(de)
|
1988-02-01 |
1989-09-06 |
F.H. FAULDING & CO. LTD. |
Tetracyclin-Dosisform
|
US4861596A
(en)
*
|
1988-03-21 |
1989-08-29 |
Pfizer Inc. |
Rolled matrix device having enhanced ability to unroll and method for its production
|
DE3812567A1
(de)
|
1988-04-15 |
1989-10-26 |
Basf Ag |
Verfahren zur herstellung pharmazeutischer mischungen
|
MC2025A1
(fr)
|
1988-04-20 |
1990-04-25 |
Asta Pharma Ag |
Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
JP2681373B2
(ja)
*
|
1988-07-18 |
1997-11-26 |
塩野義製薬株式会社 |
徐放性製剤の製造法
|
US4959219A
(en)
*
|
1988-08-15 |
1990-09-25 |
Fisons Corporation |
Coating barriers comprising ethyl cellulose
|
GB8820327D0
(en)
|
1988-08-26 |
1988-09-28 |
May & Baker Ltd |
New compositions of matter
|
US4983730A
(en)
*
|
1988-09-02 |
1991-01-08 |
Hoechst Celanese Corporation |
Water soluble cellulose acetate composition having improved processability and tensile properties
|
FI894611A
(fi)
|
1988-09-30 |
1990-03-31 |
May & Baker Ltd |
Granulaera farmaceutiska preparat.
|
US5178868A
(en)
*
|
1988-10-26 |
1993-01-12 |
Kabi Pharmacia Aktiebolaq |
Dosage form
|
US4996047A
(en)
*
|
1988-11-02 |
1991-02-26 |
Richardson-Vicks, Inc. |
Sustained release drug-resin complexes
|
CA2002492A1
(en)
|
1988-11-11 |
1990-05-11 |
Sandra T. A. Malkowska |
Pharmaceutical ion exchange resin composition
|
US5330766A
(en)
*
|
1989-01-06 |
1994-07-19 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
US5202128A
(en)
*
|
1989-01-06 |
1993-04-13 |
F. H. Faulding & Co. Limited |
Sustained release pharmaceutical composition
|
CA2007181C
(en)
*
|
1989-01-06 |
1998-11-24 |
Angelo Mario Morella |
Sustained release pharmaceutical composition
|
US5196203A
(en)
*
|
1989-01-06 |
1993-03-23 |
F. H. Faulding & Co. Limited |
Theophylline dosage form
|
CA2007055A1
(en)
|
1989-01-06 |
1990-07-06 |
Garth Boehm |
Theophylline dosage form
|
US5744166A
(en)
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
US4956182A
(en)
|
1989-03-16 |
1990-09-11 |
Bristol-Myers Company |
Direct compression cholestyramine tablet and solvent-free coating therefor
|
US5326572A
(en)
|
1989-03-23 |
1994-07-05 |
Fmc Corporation |
Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
|
US5007790A
(en)
*
|
1989-04-11 |
1991-04-16 |
Depomed Systems, Inc. |
Sustained-release oral drug dosage form
|
US5126145A
(en)
*
|
1989-04-13 |
1992-06-30 |
Upsher Smith Laboratories Inc |
Controlled release tablet containing water soluble medicament
|
US5122384A
(en)
*
|
1989-05-05 |
1992-06-16 |
Kv Pharmaceutical Company |
Oral once-per-day organic nitrate formulation which does not induce tolerance
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
US5002774A
(en)
*
|
1989-06-08 |
1991-03-26 |
Erbamont, Inc. |
Sustained release pharmaceutical tablet
|
DK161743C
(da)
*
|
1989-07-03 |
1992-02-17 |
Niro Atomizer As |
Fremgangsmaade og apparat til agglomerering af et pulverformigt materiale
|
DE415693T1
(de)
|
1989-08-28 |
1991-10-17 |
Arizona Technology Development Corp., Tucson, Ariz. |
Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit.
|
EP0418596A3
(en)
*
|
1989-09-21 |
1991-10-23 |
American Cyanamid Company |
Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
|
US5178878A
(en)
|
1989-10-02 |
1993-01-12 |
Cima Labs, Inc. |
Effervescent dosage form with microparticles
|
US5169645A
(en)
|
1989-10-31 |
1992-12-08 |
Duquesne University Of The Holy Ghost |
Directly compressible granules having improved flow properties
|
IL96311A
(en)
|
1989-12-01 |
1995-05-26 |
Abbott Lab |
Medications with delayed release
|
US5248516A
(en)
*
|
1989-12-19 |
1993-09-28 |
Fmc Corporation |
Film-forming composition: method of producing same and use for coating pharmaceuticals and foods and the like
|
US5258436A
(en)
*
|
1989-12-19 |
1993-11-02 |
Fmc Corporation |
Film-forming composition; method of producing same and use for coating pharmaceuticals and foods and the like
|
JPH0674206B2
(ja)
|
1989-12-28 |
1994-09-21 |
田辺製薬株式会社 |
放出制御型製剤およびその製法
|
IE66933B1
(en)
*
|
1990-01-15 |
1996-02-07 |
Elan Corp Plc |
Controlled absorption naproxen formulation for once-daily administration
|
US5229131A
(en)
|
1990-02-05 |
1993-07-20 |
University Of Michigan |
Pulsatile drug delivery system
|
US5158777A
(en)
|
1990-02-16 |
1992-10-27 |
E. R. Squibb & Sons, Inc. |
Captopril formulation providing increased duration of activity
|
US5206030A
(en)
*
|
1990-02-26 |
1993-04-27 |
Fmc Corporation |
Film-forming composition and use for coating pharmaceuticals, foods and the like
|
KR0168849B1
(ko)
|
1990-04-12 |
1999-01-15 |
요시또시 가즈오 |
피목 조성물 및 그의 제조방법
|
JP2542122B2
(ja)
*
|
1990-04-18 |
1996-10-09 |
旭化成工業株式会社 |
球状核、球形顆粒およびその製造方法
|
IE61651B1
(en)
|
1990-07-04 |
1994-11-16 |
Zambon Spa |
Programmed release oral solid pharmaceutical dosage form
|
WO1992001446A1
(en)
|
1990-07-20 |
1992-02-06 |
Aps Research Limited |
Sustained-release formulations
|
JPH0481086A
(ja)
|
1990-07-20 |
1992-03-13 |
Mitsubishi Electric Corp |
動き適応型走査線補間装置
|
FR2665357B1
(fr)
|
1990-07-31 |
1995-03-31 |
Aiache Jean Marc |
Procede de preparation d'une forme galenique bio-adhesive et forme galenique ainsi preparee.
|
DK0472502T3
(da)
*
|
1990-08-24 |
1995-10-09 |
Spirig Ag |
Fremgangsmåde til fremstilling af pellets
|
US5156850A
(en)
|
1990-08-31 |
1992-10-20 |
Alza Corporation |
Dosage form for time-varying patterns of drug delivery
|
US5102668A
(en)
|
1990-10-05 |
1992-04-07 |
Kingaform Technology, Inc. |
Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
|
SE9003296L
(sv)
|
1990-10-16 |
1992-04-17 |
Kabi Pharmacia Ab |
Foerfarande foer att formulera laekemedel
|
SE9003665D0
(sv)
|
1990-11-16 |
1990-11-16 |
Kabivitrum Ab |
Morphine prodrugs
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
US5387421A
(en)
|
1991-01-31 |
1995-02-07 |
Tsrl, Inc. |
Multi stage drug delivery system
|
GEP19971086B
(en)
|
1991-02-22 |
1997-12-02 |
Tillotts Pharma Ag |
Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
|
US5403593A
(en)
|
1991-03-04 |
1995-04-04 |
Sandoz Ltd. |
Melt granulated compositions for preparing sustained release dosage forms
|
GB9104854D0
(en)
|
1991-03-07 |
1991-04-17 |
Reckitt & Colmann Prod Ltd |
Sustained release compositions
|
US5273758A
(en)
|
1991-03-18 |
1993-12-28 |
Sandoz Ltd. |
Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
|
US5132142A
(en)
*
|
1991-03-19 |
1992-07-21 |
Glatt Gmbh |
Apparatus and method for producing pellets by layering power onto particles
|
AU1537292A
(en)
*
|
1991-04-16 |
1992-11-17 |
Nippon Shinyaku Co. Ltd. |
Method of manufacturing solid dispersion
|
TW209174B
(de)
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
DK0585355T3
(da)
*
|
1991-05-20 |
1995-06-06 |
Tanabe Seiyaku Co |
Flerlagspræparat med reguleret frigivelse
|
US5286497A
(en)
|
1991-05-20 |
1994-02-15 |
Carderm Capital L.P. |
Diltiazem formulation
|
US5226902A
(en)
|
1991-07-30 |
1993-07-13 |
University Of Utah |
Pulsatile drug delivery device using stimuli sensitive hydrogel
|
KR100221695B1
(ko)
*
|
1991-08-12 |
1999-09-15 |
그린 마틴, 브라이언 쥐 테슬리 |
약학적 구상 제형
|
MX9205106A
(es)
|
1991-09-06 |
1993-05-01 |
Johnson & Johnson |
Composiciones que comprenden un material de tramadol y cualquiera de codeina, oxicodona o hidrocodona y su uso
|
ES2120451T7
(es)
|
1991-09-06 |
2009-11-05 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Composicion que comprende un compuesto de tramadol y acetaminofeno, y su uso.
|
US5223541A
(en)
|
1991-09-13 |
1993-06-29 |
Mcneilab, Inc. |
Tramadol n-oxide material, enantiomers and compositions thereof, and their use
|
GB9121204D0
(en)
|
1991-10-04 |
1991-11-20 |
Euro Celtique Sa |
Medicament
|
KR100205276B1
(ko)
|
1991-10-04 |
1999-07-01 |
가마쿠라 아키오 |
서방성 정제
|
US5288502A
(en)
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
WO1993007859A1
(en)
|
1991-10-23 |
1993-04-29 |
Warner-Lambert Company |
Novel pharmaceutical pellets and process for their production
|
AU661723B2
(en)
|
1991-10-30 |
1995-08-03 |
Mcneilab, Inc. |
Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug
|
US5162117A
(en)
|
1991-11-22 |
1992-11-10 |
Schering Corporation |
Controlled release flutamide composition
|
DE4138513A1
(de)
|
1991-11-23 |
1993-05-27 |
Basf Ag |
Feste pharmazeutische retardform
|
US5656295A
(en)
*
|
1991-11-27 |
1997-08-12 |
Euro-Celtique, S.A. |
Controlled release oxycodone compositions
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5273760A
(en)
|
1991-12-24 |
1993-12-28 |
Euroceltigue, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5286493A
(en)
*
|
1992-01-27 |
1994-02-15 |
Euroceltique, S.A. |
Stabilized controlled release formulations having acrylic polymer coating
|
GB9202464D0
(en)
*
|
1992-02-05 |
1992-03-18 |
Danbiosyst Uk |
Composition for nasal administration
|
US5167964A
(en)
|
1992-02-14 |
1992-12-01 |
Warner-Lambert Company |
Semi-enteric drug delivery systems and methods for preparing same
|
US5262173A
(en)
|
1992-03-02 |
1993-11-16 |
American Cyanamid Company |
Pulsatile once-a-day delivery systems for minocycline
|
SE9200858L
(sv)
|
1992-03-20 |
1993-09-21 |
Kabi Pharmacia Ab |
Metod för framställning av pellets med fördröjd frisättning
|
US5260068A
(en)
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
US5518730A
(en)
*
|
1992-06-03 |
1996-05-21 |
Fuisz Technologies Ltd. |
Biodegradable controlled release flash flow melt-spun delivery system
|
DE4220782A1
(de)
|
1992-06-25 |
1994-01-05 |
Basf Ag |
Verfahren zur Herstellung von festen pharmazeutischen Retardformen
|
SE9202250D0
(sv)
*
|
1992-07-29 |
1992-07-29 |
Gacell Lab Ab |
Controlled release morphine preparation
|
EP0653935B1
(de)
|
1992-08-05 |
2002-05-08 |
F.H. FAULDING & CO. LIMITED |
Granulierte pharmazeutische zusammensetzung
|
US5324351A
(en)
|
1992-08-13 |
1994-06-28 |
Euroceltique |
Aqueous dispersions of zein and preparation thereof
|
US5330759A
(en)
|
1992-08-26 |
1994-07-19 |
Sterling Winthrop Inc. |
Enteric coated soft capsules and method of preparation thereof
|
WO1994005262A1
(en)
|
1992-09-10 |
1994-03-17 |
F.H. Faulding & Co. Limited |
Sustained release matrix composition
|
US5386493A
(en)
*
|
1992-09-25 |
1995-01-31 |
Apple Computer, Inc. |
Apparatus and method for playing back audio at faster or slower rates without pitch distortion
|
WO1994008568A1
(en)
|
1992-10-16 |
1994-04-28 |
Nippon Shinyaku Co., Ltd. |
Method of manufacturing wax matrices
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
US5321012A
(en)
*
|
1993-01-28 |
1994-06-14 |
Virginia Commonwealth University Medical College |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
|
IT1264020B
(it)
|
1993-01-28 |
1996-09-09 |
Recordati Chem Pharm |
Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
|
US5820879A
(en)
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
US5753261A
(en)
|
1993-02-12 |
1998-05-19 |
Access Pharmaceuticals, Inc. |
Lipid-coated condensed-phase microparticle composition
|
US5654006A
(en)
|
1993-02-12 |
1997-08-05 |
Mayo Foundation For Medical Education And Research |
Condensed-phase microparticle composition and method
|
US5352683A
(en)
|
1993-03-05 |
1994-10-04 |
Virginia Commonwealth University Medical College Of Virginia |
Method for the treatment of chronic pain
|
CA2115792C
(en)
*
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
US5503846A
(en)
|
1993-03-17 |
1996-04-02 |
Cima Labs, Inc. |
Base coated acid particles and effervescent formulation incorporating same
|
SE9301057L
(sv)
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
US5436011A
(en)
|
1993-04-16 |
1995-07-25 |
Bristol-Myers Squibb Company |
Solid pharmaceutical dosage form and a method for reducing abrasion
|
ATE195252T1
(de)
|
1993-04-23 |
2000-08-15 |
Novartis Erfind Verwalt Gmbh |
Wirkstoffabgabevorrichtung mit gesteuerter freigabe
|
IL109944A
(en)
|
1993-07-01 |
1998-12-06 |
Euro Celtique Sa |
Continuous release dosage form containing morphine and a method of preparing such sustained release unit dosage forms
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
DE4329794C2
(de)
|
1993-09-03 |
1997-09-18 |
Gruenenthal Gmbh |
Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
|
US5380790A
(en)
|
1993-09-09 |
1995-01-10 |
Eastman Chemical Company |
Process for the preparation of acrylic polymers for pharmaceutical coatings
|
EP1442745A1
(de)
|
1993-10-07 |
2004-08-04 |
Euro-Celtique |
Oral anzuwendende opioidhaltige Zusammensetzungen mit verlängerter Wirkung
|
AU4449399A
(en)
|
1993-10-07 |
1999-10-14 |
Euro-Celtique S.A. |
Orally administrable opioid formulations having extended duration of effect
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US6210714B1
(en)
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
GB9401894D0
(en)
|
1994-02-01 |
1994-03-30 |
Rhone Poulenc Rorer Ltd |
New compositions of matter
|
US5458879A
(en)
|
1994-03-03 |
1995-10-17 |
The Procter & Gamble Company |
Oral vehicle compositions
|
US5843480A
(en)
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
US5484608A
(en)
|
1994-03-28 |
1996-01-16 |
Pharmavene, Inc. |
Sustained-release drug delivery system
|
DE4413350A1
(de)
|
1994-04-18 |
1995-10-19 |
Basf Ag |
Retard-Matrixpellets und Verfahren zu ihrer Herstellung
|
US5411745A
(en)
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
US5958458A
(en)
|
1994-06-15 |
1999-09-28 |
Dumex-Alpharma A/S |
Pharmaceutical multiple unit particulate formulation in the form of coated cores
|
US5460826A
(en)
*
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
US5529787A
(en)
|
1994-07-07 |
1996-06-25 |
Alza Corporation |
Hydromorphone therapy
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US20020006438A1
(en)
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
JPH08157392A
(ja)
|
1994-12-01 |
1996-06-18 |
Kanegafuchi Chem Ind Co Ltd |
放出制御型製剤
|
US5958551A
(en)
|
1995-08-31 |
1999-09-28 |
Garcia-Ochoa; Jorge-Isaac |
Structural element
|
US5834024A
(en)
|
1995-01-05 |
1998-11-10 |
Fh Faulding & Co. Limited |
Controlled absorption diltiazem pharmaceutical formulation
|
US5616707A
(en)
|
1995-01-06 |
1997-04-01 |
Crooks; Peter A. |
Compounds which are useful for prevention and treatment of central nervous system disorders
|
IL139728A
(en)
|
1995-01-09 |
2003-06-24 |
Penwest Pharmaceuticals Compan |
Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
|
US5585115A
(en)
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
US5534263A
(en)
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5567441A
(en)
|
1995-03-24 |
1996-10-22 |
Andrx Pharmaceuticals Inc. |
Diltiazem controlled release formulation
|
US5558879A
(en)
*
|
1995-04-28 |
1996-09-24 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water soluble drugs in which a passageway is formed in situ
|
US5674895A
(en)
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US5945124A
(en)
|
1995-07-05 |
1999-08-31 |
Byk Gulden Chemische Fabrik Gmbh |
Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
|
US5931809A
(en)
*
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
GB9514451D0
(en)
|
1995-07-14 |
1995-09-13 |
Chiroscience Ltd |
Sustained-release formulation
|
CA2223629A1
(en)
|
1995-07-14 |
1997-02-06 |
Nicholas Robert Pope |
Therapeutic use of d-threo-methylphenidate
|
DE19526759A1
(de)
|
1995-07-21 |
1997-01-23 |
Wacker Chemie Gmbh |
Redispergierbare, vernetzbare Dispersionspulver
|
DE19529445A1
(de)
|
1995-08-10 |
1997-02-13 |
Basf Ag |
Verwendung von Polymerisaten auf Basis von Ethylen, (Meth)acrylsäureestern und (Meth)acrylsäure zum Beschichten oder Versiegeln von Verbundsicherheitsglasscheiben
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
US5811126A
(en)
|
1995-10-02 |
1998-09-22 |
Euro-Celtique, S.A. |
Controlled release matrix for pharmaceuticals
|
AUPN605795A0
(en)
*
|
1995-10-19 |
1995-11-09 |
F.H. Faulding & Co. Limited |
Analgesic pharmaceutical composition
|
US5807579A
(en)
|
1995-11-16 |
1998-09-15 |
F.H. Faulding & Co. Limited |
Pseudoephedrine combination pharmaceutical compositions
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
SE9600046D0
(sv)
|
1996-01-05 |
1996-01-05 |
Astra Ab |
New pharmaceutical formulation
|
US5840332A
(en)
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
WO1997026865A1
(en)
|
1996-01-29 |
1997-07-31 |
Edward Mendell Co., Inc. |
Sustained release excipient
|
US5783212A
(en)
|
1996-02-02 |
1998-07-21 |
Temple University--of the Commonwealth System of Higher Education |
Controlled release drug delivery system
|
WO1997032093A1
(en)
|
1996-03-01 |
1997-09-04 |
Bhp Steel (Jla) Pty. Ltd. |
Insulation system
|
US6245351B1
(en)
|
1996-03-07 |
2001-06-12 |
Takeda Chemical Industries, Ltd. |
Controlled-release composition
|
DE69722191T2
(de)
|
1996-03-08 |
2004-04-01 |
Nycomed Danmark Aps |
Dosiszusammensetzung mit modifizierter freigabe aus vielen einzelkomponenten
|
PT914097E
(pt)
|
1996-03-12 |
2002-06-28 |
Alza Corp |
Composicao e forma de dosagem compreendendo antagonista de opioide
|
JP3511042B2
(ja)
|
1996-06-28 |
2004-03-29 |
ソニー株式会社 |
ヒートシュリンクバンド用鋼板
|
US20020110595A1
(en)
|
1996-06-28 |
2002-08-15 |
Basf Corporation |
Slow release pharmaceutical compositions
|
DE19630035A1
(de)
|
1996-07-25 |
1998-01-29 |
Asta Medica Ag |
Tramadol Multiple Unit Formulierungen
|
TW477708B
(en)
|
1996-09-13 |
2002-03-01 |
Shionogi & Amp Co |
Use of the thermal change to produce a substained release preparations and a process for their production
|
PT932388E
(pt)
|
1996-09-30 |
2006-07-31 |
Alza Corp |
Forma de dosagem e metodo para administracao de farmacos
|
FR2753904B1
(fr)
|
1996-10-01 |
1998-10-30 |
Gattefosse Ets Sa |
Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
|
US6375987B1
(en)
|
1996-10-01 |
2002-04-23 |
Gattefossé, S.A. |
Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
|
FR2754710B1
(fr)
|
1996-10-22 |
1998-12-31 |
Prographarm Lab |
Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle
|
DE19647692C2
(de)
|
1996-11-05 |
2002-06-20 |
Schuelke & Mayr Gmbh |
Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion
|
DE19653631A1
(de)
|
1996-12-20 |
1998-06-25 |
Basf Coatings Ag |
Verfahren zum Herstellen von durch Strahlung vernetzbaren polymeren Acryl- oder Methacrylsäureestern
|
US5776856A
(en)
|
1997-02-04 |
1998-07-07 |
Isp Investments Inc. |
Soluble polymer based matrix for chemically active water insoluble components
|
US5948787A
(en)
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
BE1011045A3
(fr)
|
1997-03-14 |
1999-04-06 |
Ucb Sa |
Compositions pharmaceutiques pour la liberation controlee de substances actives.
|
US5904927A
(en)
|
1997-03-14 |
1999-05-18 |
Northeastern University |
Drug delivery using pH-sensitive semi-interpenetrating network hydrogels
|
US6155423A
(en)
|
1997-04-01 |
2000-12-05 |
Cima Labs Inc. |
Blister package and packaged tablet
|
US6024981A
(en)
|
1997-04-16 |
2000-02-15 |
Cima Labs Inc. |
Rapidly dissolving robust dosage form
|
US5840329A
(en)
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
GB9714675D0
(en)
|
1997-07-11 |
1997-09-17 |
Smithkline Beecham Plc |
Novel composition
|
US5851555A
(en)
|
1997-08-15 |
1998-12-22 |
Fuisz Technologies Ltd. |
Controlled release dosage forms containing water soluble drugs
|
US5885616A
(en)
|
1997-08-18 |
1999-03-23 |
Impax Pharmaceuticals, Inc. |
Sustained release drug delivery system suitable for oral administration
|
EA002806B1
(ru)
|
1997-09-11 |
2002-10-31 |
Нюкомед Данмарк А/С |
Многоединичные композиции с модифицированным высвобождением нестероидных противовоспалительных лекарственных веществ (nsaid)
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
JP3270450B2
(ja)
|
1997-09-26 |
2002-04-02 |
ワツカー−ケミー ゲゼルシヤフト ミツト ベシユレンクテル ハフツング |
保護コロイド−安定化されたポリマーの製法
|
US5843477A
(en)
|
1997-09-30 |
1998-12-01 |
Bayer Corporation |
Lubricants for use in tabletting
|
US6607751B1
(en)
|
1997-10-10 |
2003-08-19 |
Intellipharamaceutics Corp. |
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
|
US6066339A
(en)
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
US20040028735A1
(en)
|
1997-11-14 |
2004-02-12 |
Unchalee Kositprapa |
Pharmaceutical formulation
|
AU773642C
(en)
*
|
1997-12-22 |
2006-04-06 |
Mundipharma Pty Limited |
Opioid agonist/antagonist combinations
|
SE9704870D0
(sv)
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
CN1204890C
(zh)
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
US6251430B1
(en)
|
1998-02-04 |
2001-06-26 |
Guohua Zhang |
Water insoluble polymer based sustained release formulation
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6200604B1
(en)
|
1998-03-27 |
2001-03-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6372254B1
(en)
|
1998-04-02 |
2002-04-16 |
Impax Pharmaceuticals Inc. |
Press coated, pulsatile drug delivery system suitable for oral administration
|
US6156342A
(en)
|
1998-05-26 |
2000-12-05 |
Andex Pharmaceuticals, Inc. |
Controlled release oral dosage form
|
US6150366A
(en)
|
1998-06-15 |
2000-11-21 |
Pfizer Inc. |
Ziprasidone formulations
|
US6368625B1
(en)
|
1998-08-12 |
2002-04-09 |
Cima Labs Inc. |
Orally disintegrable tablet forming a viscous slurry
|
SE9803239D0
(sv)
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
Composition for the treatment of acute pain
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20010055613A1
(en)
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
UA67802C2
(uk)
|
1998-10-23 |
2004-07-15 |
Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. |
Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
|
US20060240105A1
(en)
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
US20080113025A1
(en)
|
1998-11-02 |
2008-05-15 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
|
US20090149479A1
(en)
|
1998-11-02 |
2009-06-11 |
Elan Pharma International Limited |
Dosing regimen
|
WO2000025752A1
(en)
|
1998-11-02 |
2000-05-11 |
Church, Marla, J. |
Multiparticulate modified release composition
|
US20080102121A1
(en)
|
1998-11-02 |
2008-05-01 |
Elan Pharma International Limited |
Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone
|
US7767708B2
(en)
|
1998-11-04 |
2010-08-03 |
Schering-Plough Animal Health Corp. |
Growth stimulant compositions
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
PE20001396A1
(es)
|
1999-01-18 |
2000-12-23 |
Gruenenthal Chemie |
Formulaciones medicamentosas retardadas que contienen una combinacion de un opioide o una sal fisiologicamente tolerables del mismo, un o-agonista
|
DE19901687B4
(de)
|
1999-01-18 |
2006-06-01 |
Grünenthal GmbH |
Opioide Analgetika mit kontrollierter Wirkstofffreisetzung
|
CA2361555A1
(en)
|
1999-02-03 |
2000-08-10 |
Powderject Research Limited |
Hydrogel particle formulations
|
US7374779B2
(en)
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
US6680071B1
(en)
|
1999-03-03 |
2004-01-20 |
R. P. Scherer Technologies, Inc. |
Opioid agonist in a fast dispersing dosage form
|
US6025502A
(en)
|
1999-03-19 |
2000-02-15 |
The Trustees Of The University Of Pennsylvania |
Enantopselective synthesis of methyl phenidate
|
US6217904B1
(en)
|
1999-04-06 |
2001-04-17 |
Pharmaquest Ltd. |
Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant
|
NZ514764A
(en)
|
1999-05-27 |
2004-04-30 |
Pfizer Prod Inc |
Ziprasidone suspension, which is taste-masked and may be used to treat psychosis
|
ES2247749T3
(es)
|
1999-07-02 |
2006-03-01 |
Cognis Ip Management Gmbh |
Microcapsulas iii.
|
EP1064912B1
(de)
|
1999-07-02 |
2004-01-28 |
Cognis Iberia, S.L. |
Mikrokapseln - I
|
DE19932603A1
(de)
|
1999-07-13 |
2001-01-25 |
Gruenenthal Gmbh |
Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
US20030118641A1
(en)
|
2000-07-27 |
2003-06-26 |
Roxane Laboratories, Inc. |
Abuse-resistant sustained-release opioid formulation
|
US6562375B1
(en)
|
1999-08-04 |
2003-05-13 |
Yamanouchi Pharmaceuticals, Co., Ltd. |
Stable pharmaceutical composition for oral use
|
SE9903236D0
(sv)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
US6264983B1
(en)
|
1999-09-16 |
2001-07-24 |
Rhodia, Inc. |
Directly compressible, ultra fine acetaminophen compositions and process for producing same
|
US6262072B1
(en)
*
|
1999-10-12 |
2001-07-17 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Orally administered antimicrobial pharmaceutical formulations of ciprofloxacin
|
BRPI0015284B8
(pt)
*
|
1999-10-29 |
2021-05-25 |
Euro Celtique S/A |
formulações de hidrocodona de liberação controlada
|
US10179130B2
(en)
*
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
EP2003134B1
(de)
|
1999-11-09 |
2011-03-02 |
Abbott Laboratories |
Hydromorphinonzusammensetzungen
|
JP2003522144A
(ja)
|
2000-02-08 |
2003-07-22 |
ユーロ−セルティーク,エス.エイ. |
オピオイドアゴニストおよびアンタゴニストを含む制御放出組成物
|
US6627223B2
(en)
|
2000-02-11 |
2003-09-30 |
Eurand Pharmaceuticals Ltd. |
Timed pulsatile drug delivery systems
|
US6419954B1
(en)
|
2000-05-19 |
2002-07-16 |
Yamanouchi Pharmaceutical Co., Ltd. |
Tablets and methods for modified release of hydrophilic and other active agents
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
US6344215B1
(en)
|
2000-10-27 |
2002-02-05 |
Eurand America, Inc. |
Methylphenidate modified release formulations
|
KR101045144B1
(ko)
|
2000-10-30 |
2011-06-30 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
CA2778114A1
(en)
|
2001-05-11 |
2002-11-21 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant opioid dosage form
|
US7052706B2
(en)
|
2001-06-08 |
2006-05-30 |
Nostrum Pharmaceuticals, Inc. |
Control release formulation containing a hydrophobic material as the sustained release agent
|
AU2002314968B2
(en)
|
2001-06-08 |
2006-12-07 |
Endo Pharmaceuticals, Inc. |
Controlled release dosage forms using acrylic polymer, and process for making the same
|
JP4848101B2
(ja)
|
2001-08-17 |
2011-12-28 |
株式会社フジモト・コーポレーション |
徐放性マイクロペレット
|
US20040253310A1
(en)
|
2001-09-21 |
2004-12-16 |
Gina Fischer |
Morphine polymer release system
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
US6863901B2
(en)
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
US20040052843A1
(en)
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
KR100540035B1
(ko)
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
DK1578350T3
(da)
|
2002-03-26 |
2009-08-10 |
Euro Celtique Sa |
Sammensætninger med gel-coating med depotvirkning
|
ES2733044T1
(es)
|
2002-04-05 |
2019-11-27 |
Mundipharma Pharmaceuticals S L |
Composición farmacéutica que contiene oxicodona y naloxona
|
US20050106249A1
(en)
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
US8557291B2
(en)
|
2002-07-05 |
2013-10-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
EP1594467A4
(de)
|
2002-07-05 |
2008-10-22 |
Collegium Pharmaceutical Inc |
Missbrauch verhindernde pharmazeutische zusammensetzungen von opioiden und anderen medikamenten
|
US20040208936A1
(en)
|
2002-07-22 |
2004-10-21 |
Roland Chorin |
Novel compositions
|
US7985422B2
(en)
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
US20040026812A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Tiy Inc. |
Apparatus for bench scale tablet-making
|
ES2358896T3
(es)
|
2002-08-15 |
2011-05-16 |
Euro-Celtique S.A. |
Composiciones farmacéuticas que comprenden un analgésico opioide.
|
US20040052844A1
(en)
|
2002-09-16 |
2004-03-18 |
Fang-Hsiung Hsiao |
Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins
|
US20050020613A1
(en)
|
2002-09-20 |
2005-01-27 |
Alpharma, Inc. |
Sustained release opioid formulations and method of use
|
EP2422775A3
(de)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestriermitteluntereinheit und zugehörige Zusammensetzungen und Verfahren
|
CA2499994C
(en)
|
2002-09-23 |
2012-07-10 |
Verion, Inc. |
Abuse-resistant pharmaceutical compositions
|
US20060003004A1
(en)
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
AU2003291103A1
(en)
|
2002-11-15 |
2004-06-15 |
Branded Products For The Future |
Pharmaceutical composition
|
ES2645930T3
(es)
|
2003-01-03 |
2017-12-11 |
Supernus Pharmaceuticals, Inc. |
Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
|
KR100712356B1
(ko)
|
2003-01-23 |
2007-05-02 |
(주)아모레퍼시픽 |
서방성 제제 및 그의 제조방법
|
US20040157784A1
(en)
|
2003-02-10 |
2004-08-12 |
Jame Fine Chemicals, Inc. |
Opiod tannate compositions
|
US7442387B2
(en)
|
2003-03-06 |
2008-10-28 |
Astellas Pharma Inc. |
Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
|
EP1782834A3
(de)
|
2003-03-13 |
2007-08-01 |
Controlled Chemicals, Inc. |
Oxycodon- konjugate mit niedrigerem missbrauch- potential und ausgedehnter tätigkeitsdauer
|
JP2006520392A
(ja)
|
2003-03-13 |
2006-09-07 |
コントロールド・ケミカルズ・インコーポレーテッド |
薬物の乱用可能性を低下させ且つ作用持続時間を延長する化合物および方法
|
BRPI0408323A
(pt)
|
2003-03-14 |
2006-03-07 |
Nirmal Mulye |
processo para a preparação de compimidos de liberação prolongada
|
SE0300831D0
(sv)
|
2003-03-26 |
2003-03-26 |
Pharmacia Ab |
New formulations and use therof
|
EP1610767B1
(de)
|
2003-03-26 |
2011-01-19 |
Egalet A/S |
Morphin-system mit kontrollierter freisetzung
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
EP1615625A4
(de)
|
2003-04-21 |
2010-12-15 |
Euro Celtique Sa |
Sicherheits-dosierform mit koextrudierten teilchen eines unerwünschten mittels und herstellungsverfahren dafür
|
IN2003MU00504A
(de)
|
2003-06-05 |
2005-05-13 |
Alembic Ltd |
|
MXPA06002455A
(es)
|
2003-09-02 |
2006-08-31 |
Pfizer Prod Inc |
Formas de dosificacion de liberacion sostenida de ziprasidona.
|
US20050053656A1
(en)
|
2003-09-05 |
2005-03-10 |
Ping Jeffrey H. |
Compositions and methods for treating pain
|
US20090304793A1
(en)
|
2003-09-22 |
2009-12-10 |
Alpharma, Inc. |
Sustained release opioid formulations and methods of use
|
US20080031901A1
(en)
|
2004-09-24 |
2008-02-07 |
Abbott Laboratories |
Sustained release monoeximic formulations of opioid and nonopioid analgesics
|
WO2005030181A1
(en)
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
US20050074493A1
(en)
|
2003-10-03 |
2005-04-07 |
Mehta Atul M. |
Extended release formulations of opioids and method of use thereof
|
HUP0303382A2
(hu)
|
2003-10-10 |
2005-08-29 |
EGIS Gyógyszergyár Rt. |
Venlafaxin-hidroklorid-tartalmú pelletek
|
MXPA06003942A
(es)
|
2003-10-10 |
2006-07-05 |
Ethypharm Sa |
Microgranulos de liberacion sostenida que contienen extracto de gingko biloba, y procedimiento para la fabricacion de los mismos.
|
BRPI0415639A
(pt)
|
2003-10-29 |
2006-12-12 |
Alza Corp |
formas de dosagem de oxicodona de liberação controlada, oral, uma vez por dia
|
JP2007517054A
(ja)
|
2003-12-31 |
2007-06-28 |
シーマ・ラブス、インコーポレイテッド |
概して線状の発泡性経口フェンタニル投薬形態および投与方法
|
US20050165038A1
(en)
|
2004-01-22 |
2005-07-28 |
Maxwell Gordon |
Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
|
GB0408308D0
(en)
|
2004-04-14 |
2004-05-19 |
Vectura Ltd |
Pharmaceutical compositions
|
US20060024361A1
(en)
|
2004-07-28 |
2006-02-02 |
Isa Odidi |
Disintegrant assisted controlled release technology
|
EP1786404A2
(de)
|
2004-09-01 |
2007-05-23 |
Euro-Celtique S.A. |
Opioid-dosierformen mit steady-state-cave proportional zur dosierung und auc und einzeldosen-cmax geringer als proportional zur dosierung
|
US20070231268A1
(en)
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
KR20070119678A
(ko)
|
2005-04-13 |
2007-12-20 |
화이자 프로덕츠 인코포레이티드 |
지속 방출되는 나노입자 조성물을 제공하기 위한주사가능한 저장소 제제 및 방법
|
US20060263429A1
(en)
|
2005-05-20 |
2006-11-23 |
Hengsheng Feng |
Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof
|
EP1917000A2
(de)
|
2005-07-07 |
2008-05-07 |
Farnam Companies, Inc. |
Pharmazeutische zusammensetzungen mit verzögerter freisetzung für hoch wasserlösliche arzneimittel
|
US20070092573A1
(en)
|
2005-10-24 |
2007-04-26 |
Laxminarayan Joshi |
Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
|
US9125833B2
(en)
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090317355A1
(en)
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US7584450B2
(en)
*
|
2006-02-17 |
2009-09-01 |
Synopsys, Inc. |
Method and apparatus for using a database to quickly identify and correct a manufacturing problem area in a layout
|
FR2898056B1
(fr)
|
2006-03-01 |
2012-01-20 |
Ethypharm Sa |
Comprimes resistant a l'ecrasement destines a eviter le detournement illicite
|
US20070212414A1
(en)
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
WO2007112574A1
(en)
|
2006-04-03 |
2007-10-11 |
Isa Odidi |
Extended release composition of venlafaxine
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US20080226734A1
(en)
|
2007-03-16 |
2008-09-18 |
Elan Corporation Plc |
Combination of a narcotic and non-narcotic analgesic
|
JPWO2008117784A1
(ja)
|
2007-03-26 |
2010-07-15 |
日本電気株式会社 |
携帯電話端末、画像表示制御方法、そのプログラムおよびプログラム記録媒体
|
WO2008140460A1
(en)
|
2007-05-16 |
2008-11-20 |
Fmc Corporation |
Solid form
|
US20110065628A1
(en)
|
2007-08-27 |
2011-03-17 |
University Of Virginia Patent Foundation |
Medication Combinations for the Treatment of Alcoholism and Drug Addiction
|
JP2010539184A
(ja)
|
2007-09-12 |
2010-12-16 |
エラン・ファルマ・インターナショナル・リミテッド |
投薬レジメン
|
KR101424653B1
(ko)
|
2007-09-21 |
2014-08-06 |
에보니크 룀 게엠베하 |
에탄올의 영향에 대하여 내성을 가지는 ph-의존성 조절 방출 제약학적 오피오이드 조성물
|
ES2337935T3
(es)
|
2007-11-09 |
2010-04-30 |
Acino Pharma Ag |
Comprimidos de accion retardada con hidromorfona.
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
US20100323016A1
(en)
|
2008-07-18 |
2010-12-23 |
Biljana Nadjsombati |
Modified release formulation and methods of use
|
JP2012500221A
(ja)
|
2008-08-15 |
2012-01-05 |
ディポメド,インコーポレイティド |
Cns障害の処理及び予防のための胃保持性医薬組成物
|
US20110237614A1
(en)
|
2008-09-16 |
2011-09-29 |
Nektar Therapeutics |
Pegylated Opioids with Low Potential for Abuse
|
WO2011106416A2
(en)
|
2010-02-24 |
2011-09-01 |
Cima Labs Inc. |
Abuse-resistant formulations
|
DK2826467T3
(en)
|
2010-12-22 |
2017-10-16 |
Purdue Pharma Lp |
INCLUDED, MANIPULATION-PROPOSED SLOW-DELIVERY DOSAGE FORMS
|
AU2012235878B2
(en)
|
2011-03-25 |
2015-10-15 |
Purdue Pharma L.P. |
Controlled release pharmaceutical dosage forms
|
EP2765998A1
(de)
*
|
2011-10-11 |
2014-08-20 |
Ranbaxy Laboratories Limited |
Gastroretentives dosiersystem und verfahren zu seiner herstellung
|
US20140161879A1
(en)
|
2012-07-31 |
2014-06-12 |
Zogenix, Inc. |
Treating pain in patients with hepatic impairment
|